AI-generated summary
The authors report early observations on six Parkinson's disease patients who used homemade light helmets or an intranasal LED device emitting red and near-infrared light. Progress was judged by patients, spouses, or doctors, and the authors report that most initial signs and symptoms improved over up to 24 months. The authors note the study is a small, early observational report and lays groundwork for future clinical trials.
- Participants
- 6
- Who or what was studied
- Six patients with Parkinson's disease
- Wavelengths
- 670, 810, 850, 660 nm
- Limits stated in the abstract
- The abstract describes a small, early observational study of six patients with subjective progress assessments and no control group.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 850 nm, 660 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Light-emitting diode, Near-infrared. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.